WallStSmart
LUCD

Lucid Diagnostics Inc

NASDAQ: LUCD · HEALTHCARE · MEDICAL DEVICES

$1.02
-2.43% today

Updated 2026-06-03

Market cap
$187.53M
P/E ratio
P/S ratio
36.53x
EPS (TTM)
$-0.34
Dividend yield
52W range
$1 – $2
Volume
0.9M

Lucid Diagnostics Inc (LUCD) Financial statements

SEC filings — annual and quarterly data.

Profit margin
-1,232.68%
Operating margin
-1,054.82%
ROE
-711.00%
ROA
-92.10%
Debt/equity
6.70x

Margin trends — annual

Gross margin Operating margin Profit margin
YearRevenueNet incomeGross marginOp. marginProfit margin
2018$-1.13M
2019$0.00$-4.42M
2020$0.00$-8.28M
2021$500000.00$-28.08M-17.00%-5,483.80%-5,615.60%
2022$377000.00$-56.17M-858.62%-14,899.47%-14,899.47%
2023$2.43M$-52.67M-249.18%-1,996.79%-2,169.11%
2024$4.35M$-45.53M-90.20%-1,059.64%-1,047.61%
2025$4.71M$-58.01M-60.26%-1,054.82%-1,232.68%

Frequently asked questions

What is Lucid Diagnostics Inc's revenue?

Lucid Diagnostics Inc's trailing twelve-month revenue is $5.13M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is LUCD?

In its most recent fiscal year, LUCD ran a gross margin of -60.26%, an operating margin of -1,054.82%, and a net margin of -1,232.68%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does LUCD generate?

LUCD produced $-46.68M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is LUCD's balance sheet healthy?

LUCD holds $34.70M in cash and equivalents against — in long-term debt, on $10.94M of shareholder equity. That debt is best read against the cash flow the business throws off each year.